INSIGHTS ON LIQUID DOSE MANUFACTURING

• Enhancing Biological Indicators With Enzyme Indicators

  Achieve greater process assurance in decontamination cycles. Combining traditional indicators with rapid, quantitative enzyme data reveals performance trends to optimize validation.

• Effective Strategies To Minimize Product Loss During Fill Finish

  Every drop of high-value biologic lost in fill finish is money left on the table. Learn practical strategies to protect your yield.

• What Makes A RABS Design Effective In Aseptic Manufacturing?

  Choosing among passive open, active open, and closed barrier configurations is only the first step. Airflow, equipment geometry, and intervention frequency determine whether a design protects the process.

• Success Factors For Pre-Filled Syringe CMO Selection

  Within the past few decades, there has been a steady increase in the use of pre-filled syringes (PFS) for parenteral administration of biologics, biosimilars, and other drugs.

• Beyond Drug Delivery: Three Lenses For Selecting An On-Body Platform

  9/10/2026

  Choosing a wearable delivery platform goes beyond technical fit. Discover how performance, patient experience, development readiness, and lifecycle planning shape long-term success.

• Raise Your Standards With Downflow Booth Airflow Containment

  1/30/2026

  Ensure personnel safety during hazardous material handling by mastering airflow dynamics and containment screens. Learn to achieve low exposure levels through advanced HEPA filtration methods.

• Turning A "Brick Dust" Compound Into A Clinically Viable Oral Formulation

  11/2/2026

  Advanced wet milling and particle stabilization improve solubility, enhance bioavailability, and support scalable manufacturing for complex oral drug development programs.

• A Modular, Fully Automated Aseptic Processing Solution

  5/12/2026

  Automated, no-touch aseptic processing enhances batch integrity and throughput. Explore how modular robotics and recipe-driven filling adapt to the complex demands of modern drug development.

• CAR-T Cell Therapy For Cancer: The Patient's In The Process

  7/21/2026

  Autologous cell therapies require absolute process repeatability. Learn how automated cryovial filling protects cell viability and eliminates manual variability.